Condensate-Promoting ENL Mutation Drives Tumorigenesis In Vivo Through Dynamic Regulation of Histone Modifications and Gene Expression
Cancer Discovery · 02.08.2024 · 14 (8) · 1522-1546
DOI: 10.1158/2159-8290.cd-23-0876 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Discovery, online erschienen am 23.04.2024. Verfasst von Yiman Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Mutation. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health (NIH), NIAID NIH HHS.
Abstract (Originalsprache)
Gain-of-function mutations in the histone acetylation “reader” eleven-nineteen-leukemia (ENL), found in acute myeloid leukemia (AML) and Wilms tumor, are known to drive condensate formation and gene activation in cellular systems. However, their role in tumorigenesis remains unclear. Using a conditional knock-in mouse model, we show that mutant ENL perturbs normal hematopoiesis, induces aberrant expansion of myeloid progenitors, and triggers rapid onset of aggressive AML. Mutant ENL alters developmental and inflammatory gene programs in part by remodeling histone modifications. Mutant ENL forms condensates in hematopoietic stem/progenitor cells at key leukemogenic genes, and disrupting condensate formation via mutagenesis impairs its chromatin and oncogenic function. Moreover, treatment with an acetyl-binding inhibitor of the mutant ENL displaces these condensates from target loci, inhibits mutant ENL-induced chromatin changes, and delays AML initiation and progression in vivo. Our study elucidates the function of ENL mutations in chromatin regulation and tumorigenesis and demonstrates the potential of targeting pathogenic condensates in cancer treatment. Significance: A direct link between ENL mutations, condensate formation, and tumorigenesis is lacking. This study elucidates the function and mechanism of ENL mutations in leukemogenesis, establishing these mutations as bona fide oncogenic drivers. Our results also support the role of condensate dysregulation in cancer and reveal strategies to target pathogenic condensates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
- Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
- Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
- Cancer Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
- VMD-PhD Program, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
- Immunology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
ORCID-Profile: Yiman Liu, Qinglan Li, Lele Song, Chujie Gong, Sylvia Tang, Krista A Budinich, Ashley Vanderbeck, Kaeli M Mathias, Gerald B Wertheim, Son C Nguyen, Riley Outen, Eric F Joyce, Ivan Maillard, Liling Wan
Förderung
- NCI NIH HHS
- National Institutes of Health (NIH)
- NIAID NIH HHS
- University of Pennsylvania (Penn)
- NHGRI NIH HHS
- Pew Charitable Trusts (PCT)
- American Society of Hematology (ASH)
- American Cancer Society (ACS)
Zitieren
APA
Liu, Y., Li, Q., Song, L., Gong, C., Tang, S., Budinich, K. A., Vanderbeck, A., Mathias, K. M., Wertheim, G. B., Nguyen, S. C., Outen, R., Joyce, E. F., Maillard, I., & Wan, L. (2024). Condensate-Promoting ENL Mutation Drives Tumorigenesis In Vivo Through Dynamic Regulation of Histone Modifications and Gene Expression. Cancer Discovery, 14(8), 1522-1546. https://doi.org/10.1158/2159-8290.cd-23-0876
Vancouver
Liu Y, Li Q, Song L, Gong C, Tang S, Budinich KA, et al. Condensate-Promoting ENL Mutation Drives Tumorigenesis In Vivo Through Dynamic Regulation of Histone Modifications and Gene Expression. Cancer Discovery. 2024;14(8):1522-1546. doi:10.1158/2159-8290.cd-23-0876
BibTeX
@article{Liu2024,
author = {Liu, Yiman and Li, Qinglan and Song, Lele and Gong, Chujie and Tang, Sylvia and Budinich, Krista A and Vanderbeck, Ashley and Mathias, Kaeli M and Wertheim, Gerald B and Nguyen, Son C and Outen, Riley and Joyce, Eric F and Maillard, Ivan and Wan, Liling},
title = {Condensate-Promoting ENL Mutation Drives Tumorigenesis In Vivo Through Dynamic Regulation of Histone Modifications and Gene Expression},
journal = {Cancer Discovery},
year = {2024},
volume = {14},
number = {8},
pages = {1522--1546},
doi = {10.1158/2159-8290.cd-23-0876}
}
EUVIMED